Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: A randomized clinical trial

Journal of AAPOS

Volumn 13, Issue 4, 2009, Pages 384-390

  Plager, David A ^a   Whitson, Jess T ^b   Netland, Peter A ^c   Vijaya, Lingam ^d   Sathyan, Parthasarathy ^e   Sood, Devindra ^f   Krishnadas, S R ^e   Robin, Alan L ^g,h   Gross, Robert D ^b,i   Scheib, Sally A ⁱ   Scott, Haydn ⁱ   Dickerson, Jaime E ⁱ  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Hamilton Eye Institute   (United States)

^d MEDICAL RESEARCH FOUNDATION   (India)

^e ARAVIND EYE HOSPITAL   (India)

^f Glaucoma Imaging Centre   (India)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

ⁱ ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARBONATE DEHYDRATASE INHIBITOR; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL;

APHAKIA; ARTICLE; BRADYCARDIA; CHILD; CLINICAL TRIAL; CONGENITAL GLAUCOMA; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; EYE DISCHARGE; EYE DISCOMFORT; EYE IRRITATION; FEMALE; GLAUCOMA; HUMAN; HYPOTENSION; INFANT; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; OCULAR PRURITUS; PHOTOPHOBIA; PRESCHOOL CHILD; PRESSURE MEASUREMENT; PRIMARY GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TONOMETRY; TREATMENT RESPONSE; VISUAL ACUITY;

ANTIHYPERTENSIVE AGENTS; BETAXOLOL; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GELS; GLAUCOMA; HUMANS; INFANT; INFANT, NEWBORN; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC SOLUTIONS; SUSPENSIONS; TIMOLOL; TONOMETRY, OCULAR; VISUAL ACUITY;

EID: 68349122699     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2009.04.017     Document Type: Article

References (17)

1. Kanner E.M., and Netland P.A. Medical therapy of pediatric glaucoma. Contemp Ophthalmol 7 (2008) 1-8
2. Altuna J.C., Greenfield D.S., Wand M., Liebmann J.M., Taglia D.P., Kaufman P.L., et al. Latanoprost in glaucoma associated with Sturge-Weber syndrome. J Glaucoma 8 (1999) 199-203
3. Enyedi L.B., and Freedman S.F. Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol 47 Suppl (2002) S129-S132
4. Donohue E.K., and Wilensky J.T. Dorzolamide: A review. Semin Ophthalmol 12 (1997) 119-126
5. Portellos M., Buckley E.G., and Freedman S.F. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 2 (1998) 43-47
6. Ott E.Z., Mills M.D., Arango S., Getson A.J., Assaid C.A., Adamsons I.A., et al. A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years. Arch Ophthalmol 123 (2005) 1177-1186
7. Hoskins Jr. H.D., Hetherington Jr. J., Magee S.D., Naykhin R., and Migliazzo C.V. Clinical experience with timolol in childhood glaucoma. Arch Ophthalmol 103 (1985) 1163-1165
8. Zimmerman T.J., Kooner K.S., and Morgan K.S. Safety and efficacy of timolol in pediatric glaucoma. Surv Ophthalmol 28 Suppl (1983) S262-S264
9. Whitson J.T., Roarty J.D., Vijaya L., Robin A.L., Gross R.D., Landry T.A., et al. Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: A randomized clinical trial. J AAPOS 12 (2008) 239-246
10. Avramov M.N., and White P.F. Methods for monitoring the level of sedation. Crit Care Clinics 11 (1995) 803-826
11. Chernik D.A., Gillings D., Laine H., Hendler J., Silver J.M., Davidson A.B., et al. Validity and reliability of the Observer's Assessment of Alertness Scale: Study with intravenous midazolam. J Clin Psychopharm 10 (1990) 244-251
12. DuBiner H., Cooke D., Dirks M., Stewart W.C., VanDenburgh A.M., Felix C., et al. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: A 30-day comparison with latanoprost. Surv Ophthalmol 45 Suppl (2001) S353-S360
13. Boger W.P., and Walton D.S. Timolol in uncontrolled childhood glaucomas. Ophthalmology 88 (1981) 253-258
14. McMahon C.D., Hetherington Jr. J., Hoskins Jr. H.D., and Shaffer R.N. Timolol and pediatric glaucomas. Ophthalmology 88 (1981) 249-252
15. Weinreb R.N., Caldwell D.R., Goode S.M., Horwitz B.L., Laibowitz R., Shrader C.E., et al. A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution. Am J Ophthalmol 110 (1990) 189-192
16. Schenker H.I., and Silver L.H. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study. Am J Ophthalmol 130 (2000) 145-150
17. Timolol GFS [package insert] (2007), Alcon Laboratories, Inc, Fort Worth (TX)